Anti-doping news

PUBLIC DISCLOSURES

The following athletes committed an anti-doping rule violation in connection with the Olympic Games Rio 2016. They were excluded from the Games their respective results in the Olympic Games Rio 2016 were disqualified and the IWF is taking over the result management of their cases in terms of sanctions beyond the Olympic Games. ZIELINSKI, Tomasz (POL) - norandrosterone (S1.1 Anabolic Agents) USUKHBAYAR, Chagnaadorj (MGL) - testosterone (S1.1 Anabolic Agents) There is no final decision as regards the measures and/or sanctions relating to the following Athletes’ Rio Olympic Games participation yet: SINCRAIAN, Gabriel (ROU) - testosterone (S1.1 Anabolic Agents) ARTYKOV, Izzat (KGZ) - strychnine (S6 Stimulants) The IWF will not make any further comments on the cases until they are closed. Updated on

WADA 2017 Prohibited List published

The World Anti-Doping Agency (WADA) published the 2017 List of Prohibited Substances and Methods; along with, the 2017 Summary of Major Modifications and Explanatory Notes. The List - which designates what substances and methods are prohibited both in- and out-of-competition, and which substances are banned in particular sports - was approved by the Executive Committee on 21 September and comes into force on 1 January 2017. It should be noted that, for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they can be accommodated via the International Standard for Therapeutic Use Exemptions (ISTUE), which has overwhelming acceptance from athletes, physicians and anti-doping stakeholders worldwide. As has been the case in past years, the List will be made available as an iPhone app and on other mobile devices effective 1 January

PUBLIC DISCLOSURE

The IWF reports that as a consequence of the IOC’s reanalyses of samples from the 2012 London Olympic Games, the sample of the following Athlete has returned with an Adverse Analytical Finding: VARDANYAN Norik (ARM) – Dehydrochlormethyltestosterone (S1.1 Anabolic Agents) In line with the relevant rules and regulations, the IWF imposed mandatory provisional suspensions upon the Athlete, who remain provisionally suspended in view of potential anti-doping rule violations until his case is closed. Following the IOC’s decision, the IWF will be in a position to take over the results management of the case. Should it be determined that no anti-doping violation was committed, the relevant decision shall also be published. The IWF will not make any further comments on the case until it is closed. Amended on

PUBLIC DISCLOSURE

The IWF reports that as a consequence of the IOC’s reanalyses of samples from the 2012 London Olympic Games, the sample of the following Athlete has returned with an Adverse Analytical Finding: CIRICU, Anatoli (MDA) – Dehydrochlormethyltestosterone (S1.1 Anabolic agents) In line with the relevant rules and regulations, the IWF imposed mandatory provisional suspensions upon the Athlete, who remain provisionally suspended in view of potential anti-doping rule violations until his case is closed. Following the IOC’s decision, the IWF will be in a position to take over the results management of the case. Should it be determined that no anti-doping violation was committed, the relevant decision shall also be published. The IWF will not make any further comments on the case until it

PUBLIC DISCLOSURE

The IWF reports that sample of Ms. HSIAO Ya-Fang (TPE) has returned an Adverse Analytical Finding for (S1.1 Anabolic agent) 3-hydroxystanozolol glucuronide. As a consequence, the athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be published. The IWF will not make any further comment on the case until it is

PUBLIC DISCLOSURE

The IWF reports that sample of Mr. SZRAMIAK Krzysztof (POL) has returned an Adverse Analytical Finding for (S2. S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics) GH-Releasing Peptides – GHRP - 6. As a consequence, the athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be published. The IWF will not make any further comment on the case until it is